Antibody protein analysis chip
Latest Nuclea Biomarkers LLC Patents:
- Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
- Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
- Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
- Kinase peptides and antibodies
- Stylet
Description
FIG. 1 is a top perspective view of the antibody protein analysis chip showing my new design;
FIG. 2 is an enlarged partial view shown broken away thereof;
FIG. 3 is a back view thereof;
FIG. 4 is a cross section view taken along line 4—4 thereof;
FIG. 5 is a top view thereof;
FIG. 6 is a side view with the opposite side being a mirror image thereof; and,
FIG. 7 is a front view thereof.
Claims
The ornamental design for an antibody protein analysis chip, as shown and described.
Referenced Cited
U.S. Patent Documents
6481648 | November 19, 2002 | Zimmermann |
6602791 | August 5, 2003 | Ouellet et al. |
6613512 | September 2, 2003 | Kopf-Sill et al. |
6681616 | January 27, 2004 | Spaid et al. |
6686152 | February 3, 2004 | Singh et al. |
6692700 | February 17, 2004 | Handique |
6858184 | February 22, 2005 | Pelrine et al. |
7018520 | March 28, 2006 | Voss |
7025774 | April 11, 2006 | Freeman et al. |
Patent History
Patent number: D530021
Type: Grant
Filed: Jun 24, 2005
Date of Patent: Oct 10, 2006
Assignee: Nuclea Biomarkers LLC (Pittsfield, MA)
Inventor: Patrick J. Muraca (Pittsfield, MA)
Primary Examiner: Robert A. Delehanty
Assistant Examiner: Mark Cavanna
Attorney: Sonnenschein Nath & Rosenthal, LLP
Application Number: 29/232,958
Type: Grant
Filed: Jun 24, 2005
Date of Patent: Oct 10, 2006
Assignee: Nuclea Biomarkers LLC (Pittsfield, MA)
Inventor: Patrick J. Muraca (Pittsfield, MA)
Primary Examiner: Robert A. Delehanty
Assistant Examiner: Mark Cavanna
Attorney: Sonnenschein Nath & Rosenthal, LLP
Application Number: 29/232,958
Classifications
Current U.S. Class:
Plural Divisions (D24/226)